Reading the launch
Alibaba agreed to pay $600M to resolve U.S. allegations involving illegal pharmaceuticals, controlled substances, chemicals and pill-making equipment sold through its platforms. Alibaba acknowledged roughly 80,000 problematic sales from 2016–2024.
Reading trades.